Nifty Pharma index rises; Lupin, Cipla shares shine

NEW DELHI: Pharma shares were trading mixed with the Nifty Pharma index trading 0.2 per cent up at 9,663.1 around 12:12 pm on Monday.

Shares of Lupin (up 1.64 per cent), Cipla (up 1.24 per cent), Piramal Enterprises (up 1.03 per cent) and Cadila Healthcare (up 0.90 per cent) were among the top gainers in the index.

Biocon (down 1.67 per cent), Aurobindo Pharma (down 0.63 per cent), Glenmark Pharmaceuticals (down 0.63 per cent) and Sun Pharmaceutical Industries (down 0.14 per cent) were trading in the red.

Benchmark NSE Nifty50 index was down 9.40 points at 10,575.8 while BSE Sensex was down 79.56 points at 35,078.99 at that time.

Among the 50 stocks in the Nifty index, 21 were trading in the green, while 29 were in the red.

Shares of YES Bank, SBI, Tata Motors, Ashok Leyland, Titan Company, Bank of Baroda, ICICI Bank, Vedanta, HPCL and Cipla were among the most traded shares on the National Stock Exchange.

  • Related Posts

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    The inspection revealed incomplete manufacturing records, poor hygiene, inadequate quality-control systems and the omission of ingredients specified in approved Ayurvedic formulations. The Maharashtra Food and Drug Administration (FDA) on Thursday…

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Amneal Pharmaceuticals, Inc. announced the completion of its acquisition of Kashiv BioSciences, LLC, creating a fully integrated global biosimilars leader with end-to-end capabilities across research, development, manufacturing and commercialization. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    NHS backs delayed‑release treatment for cystinosis

    NHS backs delayed‑release treatment for cystinosis